InnoCare Pharma Limited
INCPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$453 | -$644 | -$894 | -$20 |
| Dep. & Amort. | $106 | $93 | $68 | $32 |
| Deferred Tax | $0 | $0 | $329 | $41 |
| Stock-Based Comp. | -$11 | $65 | $129 | $126 |
| Change in WC | -$18 | -$244 | -$75 | $120 |
| Other Non-Cash | $10 | $59 | -$123 | -$132 |
| Operating Cash Flow | -$366 | -$671 | -$566 | $167 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$78 | -$255 | -$370 | -$167 |
| Net Acquisitions | $0 | $1 | -$20 | -$1 |
| Inv. Purchases | -$5,805 | -$4,129 | -$1,824 | -$4,249 |
| Inv. Sales/Matur. | $6,994 | $5,044 | $413 | $2,691 |
| Other Inv. Act. | -$1 | $6 | $75 | -$4 |
| Investing Cash Flow | $1,111 | $667 | -$1,726 | -$1,730 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $164 | $31 | $325 | $50 |
| Stock Issued | $19 | $10 | $2,923 | $2,527 |
| Stock Repurch. | -$13 | -$6 | $0 | $0 |
| Dividends Paid | -$363 | -$1 | $0 | $0 |
| Other Fin. Act. | -$92 | -$32 | -$154 | -$33 |
| Financing Cash Flow | -$286 | $1 | $3,095 | $2,545 |
| Forex Effect | $17 | $26 | $140 | -$45 |
| Net Chg. in Cash | $477 | $23 | $943 | $937 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,203 | $4,180 | $3,237 | $2,301 |
| End Cash | $4,679 | $4,203 | $4,180 | $3,237 |
| Free Cash Flow | -$444 | -$926 | -$936 | -$0 |